These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21857301)

  • 1. Leveraging HIV programs to deliver an integrated package of health services: some words of caution.
    Grépin KA
    J Acquir Immune Defic Syndr; 2011 Aug; 57 Suppl 2():S77-9. PubMed ID: 21857301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No need for apologies.
    El-Sadr WM; Gonsalves G; Mugyenyi P
    J Acquir Immune Defic Syndr; 2011 Aug; 57 Suppl 2():S68-71. PubMed ID: 21857299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Game changers: why did the scale-up of HIV treatment work despite weak health systems?
    De Cock KM; El-Sadr WM; Ghebreyesus TA
    J Acquir Immune Defic Syndr; 2011 Aug; 57 Suppl 2():S61-3. PubMed ID: 21857297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical interactions between the Global Fund-supported HIV programs and the health system in Ghana.
    Atun R; Pothapregada SK; Kwansah J; Degbotse D; Lazarus JV
    J Acquir Immune Defic Syndr; 2011 Aug; 57 Suppl 2():S72-6. PubMed ID: 21857300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bridging the divide.
    El-Sadr WM; Rabkin M; Atun R; De Cock KM
    J Acquir Immune Defic Syndr; 2011 Aug; 57 Suppl 2():S59-60. PubMed ID: 21857296
    [No Abstract]   [Full Text] [Related]  

  • 6. Why did the scale-up of HIV treatment work? A case example from Malawi.
    Harries AD; Makombe SD; Libamba E; Schouten EJ
    J Acquir Immune Defic Syndr; 2011 Aug; 57 Suppl 2():S64-7. PubMed ID: 21857298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Building a durable response to HIV/AIDS: implications for health systems.
    Atun R; Bataringaya J
    J Acquir Immune Defic Syndr; 2011 Aug; 57 Suppl 2():S91-5. PubMed ID: 21857305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leveraging the private health sector to enhance HIV service delivery in lower-income countries.
    Rao P; Gabre-Kidan T; Mubangizi DB; Sulzbach S
    J Acquir Immune Defic Syndr; 2011 Aug; 57 Suppl 2():S116-9. PubMed ID: 21857294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How should access to antiretroviral treatment be measured?
    Johnson LF; Boulle A
    Bull World Health Organ; 2011 Feb; 89(2):157-60. PubMed ID: 21346928
    [No Abstract]   [Full Text] [Related]  

  • 10. A one-time-only combination: Emergency medicine exports and the TRIPS agreement under Canada's access to medicines regime.
    Weber A; Mills L
    Health Hum Rights; 2010 Jun; 12(1):109-22. PubMed ID: 20930258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV treatment and care systems: the way forward.
    Ross DA; South A; Weller I; Hakim J
    AIDS; 2012 Dec; 26 Suppl 2():S147-52. PubMed ID: 23303436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The cost of an HIV patient. Lack of funds for optimal treatment?].
    Stoll M; Schulte E; Claes C; Graf von der Schulenburg JM; Schmidt RE
    MMW Fortschr Med; 2001 Apr; 143 Suppl 1():72-7. PubMed ID: 11373789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scaling up chronic care systems: leveraging HIV programs to support noncommunicable disease services.
    Rabkin M; Nishtar S
    J Acquir Immune Defic Syndr; 2011 Aug; 57 Suppl 2():S87-90. PubMed ID: 21857304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrating HIV and maternal health services: will organizational culture clash sow the seeds of a new and improved implementation practice?
    Freedman LP
    J Acquir Immune Defic Syndr; 2011 Aug; 57 Suppl 2():S80-2. PubMed ID: 21857302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UN political declaration on HIV and AIDS: where to begin?
    Poku NK
    Lancet; 2016 Aug; 388(10046):743-4. PubMed ID: 27560262
    [No Abstract]   [Full Text] [Related]  

  • 16. TRIPS post-2005 and access to new antiretroviral treatments in southern countries: issues and challenges.
    Orsi F; D'Almeida C; Hasenclever L; Camara M; Tigre P; Coriat B
    AIDS; 2007 Oct; 21(15):1997-2003. PubMed ID: 17885289
    [No Abstract]   [Full Text] [Related]  

  • 17. AIDS: mixed news for patients: medications made more accessible in Africa and the Caribbean than in U.S.
    Sofer D
    Am J Nurs; 2004 Aug; 104(8):20. PubMed ID: 15300025
    [No Abstract]   [Full Text] [Related]  

  • 18. Viral load monitoring in resource-limited settings: a medical and public health priority.
    Ford N; Roberts T; Calmy A
    AIDS; 2012 Aug; 26(13):1719-20. PubMed ID: 22874478
    [No Abstract]   [Full Text] [Related]  

  • 19. Demand for programs for key populations in Africa from countries receiving international donor assistance.
    Ryan O; Macom J; Moses-Eisenstein M
    SAHARA J; 2012; 9(3):131-6. PubMed ID: 23237067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Public health. Global HIV/AIDS policy in transition.
    Bongaarts J; Over M
    Science; 2010 Jun; 328(5984):1359-60. PubMed ID: 20538936
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.